SecBot SecBot

BHST

BIOHARVEST SCIENCES INC.
Nasdaq· Pharmaceutical Preparations· Inc. A1· CIK 0001723464 Biotech & Drug Discovery
$1.68 −0.04 (−2.33%)
Oct 26 4:00 PM ET · prev $1.72
Market cap
$38.1M
Nano cap
Consensus
Buy
88% Buy or better · 8 analysts
Median target
$11.00
+555% · range $5.00–15.00
1 year
−84.7%
from $10.97 · Oct 27
30 days
+15.9%
from $1.45
52-week range
$1.45–10.97
−85% from high · low Sep 24
Avg volume 20D
19.7K
Sep 29 spike 69.6K
Short interest
99.0K
≈0.4% of shares · +3.9%
Days to cover
3.3
at average volume
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
14
analyzed by SecBot
SecBot read BULLISH 4 reports · 90 days
Balance 0 bearish · 1 bullish · 3 neutral oldest → newest, height = score
Avg score ·High conf. 1/4
Strongest BULLISH BioHarvest Sciences announced that its proprietary Olive Cell composition has reached commercial readiness…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 2 added (0 new), 2 trimmed or exited.

  • AnalystsBULLISH

    7 of 8 rate it Buy or better. Every target is above the price.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.063 → −$0.138 over 90 days. 0 up, 3 down in 30 days.

  • Short sellersSTEADY

    Short interest +3.9% to 99.0K shares. 3.3 days to cover, ≈0.4% of shares.

  • TrendRANGE

    3% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
ROYAL BANK OF CANADANEAR_EXIT9—
SUSQUEHANNA INTERNATIONAL GROUP, LLPDOUBLED63,658$179.5K
CITADEL ADVISORS LLCADD20,652$58.2K
UBS Group AGTRIM173$495.00
TD Waterhouse Canada Inc.ADD23,827$101.7K
JANE STREET GROUP, LLCTRIM13,083$56.8K
UBS Group AGTRIM629$2.7K
OSAIC HOLDINGS, INC.NEAR_EXIT628$2.7K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

8 analysts
Buy 88% rate it Buy or better
Strong Buy2Buy5Hold1Sell0Strong Sell0
12-month targets · 4 analysts

Price is below the lowest target. Median implies +555%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Aug 12, 2026Maxim Group
MAINTAIN
MAINTAINBuy
Aug 12, 2026Roth Capital
MAINTAIN
MAINTAINBuy

Earnings setup

Estimates
−$0.14
EPS estimate, this quarter
−120%
estimate change, 90 days
0↑ 3↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.14-$0.18–-$0.10-37.5%$9.3M
Next Q-$0.12-$0.15–-$0.07-53.3%$10.8M
Current FY🔒 Fresh data, subscribers only
Next FY-$0.34-$0.43–-$0.25-103.0%$49.6M

Short side

FINRA· Sep 30, 2026
99,046
shares short
+3.9%
vs prior settlement
3.3
days to cover
≈0.4%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 13, 2026 SEC
BioHarvest Sciences announced that its proprietary Olive Cell composition has reached commercial readiness, completing…
6-K — Impact 5/10
Oct 8, 2026 SEC
BioHarvest Sciences announced a key milestone with partner Tate & Lyle in their next-generation sweetener development…
6-K — Impact 4/10
Sep 15, 2026 SEC
BioHarvest Sciences filed two 6-K reports in a short window. The first is a routine press release announcing a…
6-K — Impact 3/10
Jun 30, 2026 Inst.
ROYAL BANK OF CANADA — NEAR_EXIT
9 shares (—)
Jun 30, 2026 Inst.
SUSQUEHANNA INTERNATIONAL GROUP, LLP — DOUBLED
63,658 shares ($179.5K)

SecBot reports

14 filings · 2 bullish · 1 bearish · 11 neutral
All BHST filing & press-release reports (14)